PreveCeutical Medical Inc (QB) (PRVCF) Share Price

https://finance.yahoo.com/news/rnai-therapeutics-market-size-expected-150200704.html

Check out Stephen Van Deventer on X.
Buss & family man. “The difference between good CEO & Great CEO. How CEO handles the storms” Chairman & CEO of @preveceuticals SEEK SAFE HARBOUR https://x.com/DeventerStephen

Pitch deck added to company website can be found by clicking "Investors" "presentations" https://www.preveceutical.com/

https://www.cnbc.com/2024/01/09/regeneron-ceo-says-gene-therapy-is-the-next-big-thing-for-biotech.html

https://www.cnbc.com/2024/01/05/cramer-names-biopharma-companies-as-industry-mergers-start-to-accrue.html

https://www.cnbc.com/2023/12/13/fed-interest-rate-decision-december-2023.html

Potential upcoming catalysts:
1. Endosane payment(s) related to sol gel
2. Funding secured
3. Announcement of partnership
4. Commencement of trials

Thx Walter

https://www.prnewswire.com/news-releases/preveceutical-initiates-preparation-of-proof-of-concept-preclinical-study-for-its-diabetes--obesity-dual-gene-therapy-program-302003747.html

https://www.marketscreener.com/quote/stock/PREVECEUTICAL-MEDICAL-INC-37333412/news/PreveCeutical-Medical-Inc-and-Endosane-Pharmaceuticals-GmbH-Announces-Innovative-Preclinical-Approa-44875494/

$PRVCF PreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Program & Disclosure Committee

https://www.newsfilecorp.com/release/158992

Vancouver, British Columbia--(Newsfile Corp. - March 20, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that PreveCeutical commenced clinical work with our selected clinical research organization (CRO) as announced on February 7, 2023, to complete the following.

Conduct a comprehensive gap analysis to both confirm current conclusions as well as identify any potential additional nonclinical studies (beyond those already underway or in the planning stage) that will be needed to support a successful initial IND and/or CTA submission.
Construction of a clinical development plan for Phase 1 through pivotal Phase 3 studies.
Authoring of the Investigational Brochure for the Client's lead peptide in the final indication of interest.
PreveCeutical has now commenced the clinical development on March 20, 2023. This work is being performed at our selected CRO's facilities in Australia.

Furthermore, the board of directors appointed a disclosure committee represented by Stephen Van Deventer, Dr Linnea Olofsson and Evan Ballantyne effective immediately.

PreveCeutical's Chief Executive Officer, Mr. Stephen Van Deventer, commented, "As we continue to meet further milestones, we are enthusiastic that this program has commenced as we plan to aggressively pursue the development so we may apply for IND (Investigative New Drug) status and complete the Phase 1 clinical trials."

Nice article posted today from Bezinga regarding $PREV and their solgel formula!
Check it out! Mr. Deventer posted it on Twitter a couple hours ago.

$PREV

Great news today! Things are starting to fall into place. Finally having this class action lawsuit settled and off $PREV back. Would like to see the share price start climbing and sticking with more good news.

$PREV

BIG NEWS today!

$PREV

$PRVCF-How could put up shit alike this opportunity if you catch me important give it up we sure it your in choice I'm gains? Your secularist your competency making a big deals about this that in check stay rightmost have no probables. A soundly about this timing I'm chilling you endurance fees it. The sounds call long is true in discovery.

All prophet for see a an is it is reflecting gains just keeps putting it up? Provence knowledge is power as indicated now timing call this right here well craft?

https://www.otcmarkets.com/.../PreveCeutical-Receives
...

Patience PAYS on this one.

It’ll pop soon.

Alternative ways to cure/help cancer patients is hot IMO.

https://ca.proactiveinvestors.com/companies/news/937693/preveceutical-files-provisional-australian-patent-application-for-blue-scorpion-venom-based-brain-cancer-treatment-937693.html

If the other Blue Scorpion stock gets FDA approval then this one is gonna rock.

Sorry Mistake Last Post should be for January 2020 not 2021 as posted Old news reported

Information posted by PREV ON CSE for January 2021 is impressive. Seems to be a great buy at this level for patient holders.

$PRVCF (CSE: PREV) Successful Completion of the COVID-19 Sol-Gel Formulation Development https://finance.yahoo.com/news/successful-completion-covid-19-sol-130000046.html

News released today

Anybody still watch this stock haven't heard a peep out of anybody lol

Hope this news is promoted well here in the states. It will make a little run I think. Canadian companies don’t report to the SEC financials and it hurts them.
I’m long here and bought another 10k today.

$PRVCF PreveCeutical Files an Application for a Provisional Patent for Sol-gel Cannabinoids https://finance.yahoo.com/news/preveceutical-files-application-provisional-patent-110000516.html?.tsrc=fin-srch

Buying !!!!

Big EPs coming 2020 as growth rate not 2025. In early lets see how it breaks out early to hold these bad boys.

Daily chart looks primed. Adding all dips

Nice green start PRVCF

Good morning PRVCF

looks like base is in at .05

When the pr’s start getting around to the right channels we will se some movement for sure. I seen some real pump and dumpers moving .05 on bs news with no filings in over a year. At least this one has some credentials to grow going forward.

PIckPen

Curling up nicely from pullback this AM

R/R from these levels it looks

Pushing nicely back to green on the day

The wheels are starting to turn a little faster now with great news today. I’m confident this will slowly gain traction going forward. No doubt some news letters will promote this as a Covid play.

Nice base forming above .05 now

Awesome day and news!!

Give the news a couple days to spread and we could see .10 possibly.

OTCX top bid now; spread closing up

That would be phenomenal.

Expecting other 10-20 cents before close

Ask getting some serious slappage.

Nice to see bid support step up at .05

.055 getting hit hard now

Very nice volume surge since resumption

Nice update out today: https://www.otcmarkets.com/stock/PRVCF/news/PreveCeutical-Prepares-for-Clinical-Trials-for-its-Sol-Gel-COVID-19-Program?id=269680

Where did you read that

Appreciate it. That's what I'm hearing as well.